ZA961954B - Heterocyclic substituted piperazinone derivatives - Google Patents

Heterocyclic substituted piperazinone derivatives

Info

Publication number
ZA961954B
ZA961954B ZA961954A ZA961954A ZA961954B ZA 961954 B ZA961954 B ZA 961954B ZA 961954 A ZA961954 A ZA 961954A ZA 961954 A ZA961954 A ZA 961954A ZA 961954 B ZA961954 B ZA 961954B
Authority
ZA
South Africa
Prior art keywords
heterocyclic substituted
piperazinone derivatives
substituted piperazinone
derivatives
heterocyclic
Prior art date
Application number
ZA961954A
Other languages
English (en)
Inventor
Timothy Paul Burkholder
Elizabeth Mary Kudlacz
Tieu-Binh Le
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA961954B publication Critical patent/ZA961954B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA961954A 1995-03-15 1996-03-11 Heterocyclic substituted piperazinone derivatives ZA961954B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40478895A 1995-03-15 1995-03-15

Publications (1)

Publication Number Publication Date
ZA961954B true ZA961954B (en) 1996-09-17

Family

ID=23601038

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961954A ZA961954B (en) 1995-03-15 1996-03-11 Heterocyclic substituted piperazinone derivatives

Country Status (21)

Country Link
US (2) US5840726A (ko)
EP (1) EP0815105B1 (ko)
JP (1) JP3825472B2 (ko)
KR (1) KR19980703032A (ko)
CN (1) CN1067068C (ko)
AR (1) AR002715A1 (ko)
AT (1) ATE206421T1 (ko)
AU (1) AU697599B2 (ko)
CA (1) CA2215333C (ko)
DE (1) DE69615670T2 (ko)
DK (1) DK0815105T3 (ko)
ES (1) ES2164235T3 (ko)
FI (1) FI973671A0 (ko)
HU (1) HUP9702149A3 (ko)
IL (1) IL117453A (ko)
NO (1) NO314693B1 (ko)
NZ (1) NZ302948A (ko)
PT (1) PT815105E (ko)
TW (1) TW464647B (ko)
WO (1) WO1996028441A1 (ko)
ZA (1) ZA961954B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2175161T3 (es) * 1995-12-18 2002-11-16 Fujisawa Pharmaceutical Co Derivados de piperazina como antagonistas de taquiquinina.
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
EP1670314A4 (en) * 2003-09-05 2009-02-25 Sequella Inc METHODS AND COMPOSITIONS INCLUDE DIAMINE AS A NEW THERAPEUTIC FOR TUBERCULOSIS
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung
FI97540C (fi) * 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1994003483A1 (en) * 1992-07-30 1994-02-17 Chiron Corporation Endothelin receptor-binding compounds
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
WO1994026735A1 (en) * 1993-05-06 1994-11-24 Merrell Dow Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
DE69615670D1 (de) 2001-11-08
PT815105E (pt) 2002-03-28
ATE206421T1 (de) 2001-10-15
EP0815105A1 (en) 1998-01-07
CN1178529A (zh) 1998-04-08
NO974205D0 (no) 1997-09-12
CA2215333A1 (en) 1996-09-19
US5840726A (en) 1998-11-24
IL117453A (en) 2000-07-26
ES2164235T3 (es) 2002-02-16
FI973671A (fi) 1997-09-12
JP3825472B2 (ja) 2006-09-27
AR002715A1 (es) 1998-04-29
AU4930696A (en) 1996-10-02
US5864045A (en) 1999-01-26
MX9706872A (es) 1997-11-29
IL117453A0 (en) 1996-07-23
DK0815105T3 (da) 2002-01-21
KR19980703032A (ko) 1998-09-05
CN1067068C (zh) 2001-06-13
NO314693B1 (no) 2003-05-05
DE69615670T2 (de) 2002-08-08
FI973671A0 (fi) 1997-09-12
TW464647B (en) 2001-11-21
AU697599B2 (en) 1998-10-08
NO974205L (no) 1997-11-13
HUP9702149A2 (hu) 1999-06-28
HUP9702149A3 (en) 1999-07-28
CA2215333C (en) 2002-01-01
EP0815105B1 (en) 2001-10-04
JPH11501917A (ja) 1999-02-16
NZ302948A (en) 2001-05-25
WO1996028441A1 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
EG24195A (en) Heterocyclic compounds
ZA9610020B (en) Heterocyclic compounds
GB9512697D0 (en) Heterocyclic compounds
GB9504361D0 (en) Heterocyclic compounds
ZA961954B (en) Heterocyclic substituted piperazinone derivatives
GB9405533D0 (en) Heterocyclic derivatives
GB9623283D0 (en) Heterocyclic derivatives
ZA962734B (en) Heterocyclic compounds
IL128224A0 (en) Substituted piperazinone derivatives
GB9511052D0 (en) Heterocyclic derivatives
GB9519666D0 (en) Heterocyclic derivatives
GB9502610D0 (en) Heterocyclic derivatives
GB9511098D0 (en) Heterocyclic derivatives
IL127114A0 (en) Substituted heterocyclic compounds
GB9425863D0 (en) Heterocyclic derivatives
GB9419524D0 (en) Heterocyclic derivatives
GB9421548D0 (en) Heterocyclic derivatives
GB9407431D0 (en) Heterocyclic derivatives
GB9419062D0 (en) Heterocyclic derivatives
GB9420755D0 (en) Heterocyclic derivatives
GB9425797D0 (en) Heterocyclic derivatives
GB9419343D0 (en) Heterocyclic derivatives
GB9402127D0 (en) Heterocyclic derivatives
GB9407433D0 (en) Heterocyclic derivatives
GB9424295D0 (en) Heterocyclic derivatives